Practice

Latest News

digestive tract | Image credit: Aliaksandr Marko - stock.adobe.com
Physician and Patient Perspectives After Starting or Switching to Amgevita in IBD

March 23rd 2024

A real-world study surveying physicians and patients on adalimumab biosimilar ABP 501 (Amgevita) in inflammatory bowel disease (IBD) found both patients initiating ABP 501 and those who had switched from the reference product had higher satisfaction levels.

prefilled syringes | Image credit: SOPONE - stock.adobe.com
Posters From AMCCBS and AAD Showcase New Technology for Biosimilar Uptake, Barriers to Self-Injectable Biologics

March 14th 2024

doctor filling syringe | Image credit: natali_mis - stock.adobe.com
The Role of Biosimilars: Advancing Access, Financial Health, and System Sustainability

March 11th 2024

syringe and vial | Image credit: Davizro Photography - stock.adobe.com
Review: Real-World Evidence Confirms Effectiveness and Safety of Adalimumab Biosimilar SB5

March 9th 2024

doctor talking to patient | Image credit: Prostock-studio - stock.adobe.com
Cardinal Health Report Showcases Biosimilar Growth, Provider and Payer Evolution, and More

February 29th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.